Klaviyo suspended your peptide brand? Compare Klaviyo vs restricted-category ESPs and find out which setup actually keeps flows running.
Plenty of peptide brand operators discover the hard way that Klaviyo’s compliance review isn’t triggered by a flagged campaign — it’s triggered by the URL you submit during onboarding. A product page with terms like “BPC-157” or “research peptide” can get the account flagged before a single email sends, leaving abandoned-cart flows and post-purchase sequences dead on arrival.
The real decision isn’t “should I use email.” It’s which infrastructure can survive this category long enough to compound retention value.
Staying on Klaviyo With a Compliance Layer
Klaviyo remains the most capable retention platform for e-commerce — conditional splits, predictive analytics, deep Shopify sync. Brands that stay on it successfully tend to do three things: register the account under a holding or parent domain that doesn’t surface restricted terminology, route all signup form URLs through a clean landing page rather than a product URL, and strip clinical language from list names and flow descriptions visible in the account dashboard.
This approach works, but the margin for error is narrow. A single support ticket that references a product name, or a connected integration that pulls product metadata containing restricted terms, can reopen the review. Recovery timelines after a Klaviyo suspension typically run two to four weeks, during which every automated flow — welcome series, win-back, post-purchase — is off. For a brand doing meaningful repeat-purchase volume, that’s a measurable revenue gap.
Migrating to a Restricted-Category ESP
Platforms like Sendlane, Omnisend, or specialized high-risk ESPs explicitly accept supplement and research-chemical senders. The compliance ceiling is higher — you’re not trying to hide the business category. The tradeoff is capability. Segmentation logic is shallower, predictive features are limited or absent, and Shopify integrations require more manual configuration to replicate what Klaviyo does natively.
For brands under roughly $30K monthly email-attributed revenue, this gap often doesn’t matter — basic flows (welcome, abandonment, post-purchase) produce most of the retention lift regardless of platform sophistication. Above that threshold, the missing segmentation starts costing real recoverable revenue.
Which Setup Fits Your Situation
If your catalog is borderline rather than explicit — nootropics, peptides sold strictly as research compounds, no dosing copy — a properly structured Klaviyo setup is defensible and worth the higher capability ceiling. If your site uses direct clinical language or you’ve already been suspended once, rebuilding on Klaviyo carries real re-suspension risk; a category-friendly ESP with solid fundamental flows is the more stable foundation.
Research Amino Marketing’s Email & Retention service handles both paths — building the account structure and flow architecture for brands staying on Klaviyo, and configuring retention systems on alternative ESPs for brands where Klaviyo isn’t viable.